Prolonged persistence of mutagenic DNA lesions in somatic cells
Michael Spencer Chapman, Peter J Campbell, Anna Maria Ranzoni(Wellcome/MRC Cambridge Stem Cell Institute), Janes Sam M, Ana Cvejic(University of Copenhagen), Anthony R. Green(Wellcome/MRC Cambridge Stem Cell Institute), Margarete A. Fabre(University of Cambridge), Michael R. Stratton(Wellcome Sanger Institute), Steffen Boettcher(University Hospital of Zurich), Matt Hoare(Cancer Research UK Cambridge Center), Elisa Laurenti(Wellcome/MRC Cambridge Stem Cell Institute), Jyoti Nangalia(Wellcome Sanger Institute), Lori D. Kregar(Wellcome Sanger Institute), Matthias Wilk, Kate H C Gowers, Iñigo Martincorena, Tim H H Coorens, Nicholas Williams, Kourosh Saeb Parsy, George S Vassiliou, Emily Mitchell, Philip S Robinson, Stanley W K Ng, Markus G. Manz(Ospedale San Giovanni Bellinzona), Kenichi Yoshida, Krishnaa T. Mahbubani(University of Cambridge)
Cited by 0
Related Papers
The cancer genome
|Nature|2009|3.5k
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
|Nucleic Acids Research|2014|2.4k
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
|Nucleic Acids Research|2010|2.3k